Device Trial Radar · NCT07370493
Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices
Last checked: Nov 20, 2026Latest source record: Jan 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
200
Planned (sponsor's estimate)
Start
Nov 1, 2025
Primary completion
Dec 2030
Study completion Dec 2030
Sponsor
- Lead sponsor
- Centinel SpineNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Avania
- First posted
- Jan 27, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety and post-operative performance profile of the prodisc® C Vivo after implantation in comparison to the relevant clinical literature.
Conditions
- Degenerative Disc Disease
- Cervical Spine Degenerative Disease
- Symptomatic Cervical Disc Disease
- Cervical Spine Degenerative Disc Disease
Interventions
Prodisc C VivoDevice
The prodisc® C Vivo device is a non-keeled cervical disc replacement prosthesis. The device is modular intervertebral disc prostheses designed to replace a diseased and/or a degenerated disc of the cervical spine in SCDD patients, thereby restoring disc height, biomechanical stability and allowing the potential for motion at the affected vertebral segment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of the Occurrence of Secondary Surgical Interventions in Patients Treated with prodisc® C Vivo at 2 LevelsTime frame: 10 year post-operative screening of prodisc C Vivo patients implanted from JAN 2010 to present
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ONZ Spine
Recklinghausen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.